Laser Therapy – The principle
The laser therapy program provided by ImmuneCells21 is based primarily on low-level soft laser. There is another type of laser therapy used for surgical purposes (hard laser), though soft lasers have become very important over the years.
The introduction of state-of-the-art multichannel laser systems (up to 12 lasers) at the start of the decade revolutionized medical low-level laser therapy (LLLT). This highly focused laser (“laser-needles”) leads to a much greater penetration depth and, furthermore, through the combination of different laser wave lengths (red, infrared, green and blue lasers) it can bring about a multitude of repairing effects in the tissue.
Additionally, thanks to consistent research and technical advancements, the laser can meanwhile be applied directly to within the damaged tissue (interstitial and intra-articular laser therapy), in order to enable more effective therapy options for even the most therapy-resistant complaints (spinal injuries, slipped discs, joint arthritis, and more).
In contrast, the use of intravenous laser therapy (“laser blood therapy”) leads to general energizing, optimizing of the metabolism, as well as strengthening of the immune system, and therefore offers a very successful opportunity for the treatment of multiple therapy-resistant illnesses. Laser treatment is particularly efficient in combination with intravenous metabolism therapy.
Furthermore, laser therapy in the form of so-called photodynamic therapy (PDT) paves the way for promising new tumor therapies, which are currently being intensively refined.
Overall, our experience have shown that there is high acceptance by patients with proven clinical effects.